PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | |type 2 diabetes |
| Sentences | 116 |
| PubMedID- 23124060 | In this study, we investigated the associations of leptin and the soluble leptin receptor (sob-r) with atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 20130841 | Introduction: the aim of this study was to investigate the effects of pioglitazone or metformin on bone mass and atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 23324539 | However, few studies have investigated the prevalence and clinical characteristics of atherosclerosis in patients with ketosis-prone type 2 diabetes. |
| PubMedID- 26177483 | Glucagon-like peptide-1 (glp-1) receptor agonists are a class of injective anti-diabetic drugs that improve glycemic control and many other atherosclerosis-related parameters in patients with type 2 diabetes (t2d). |
| PubMedID- 24843385 | Reported that parameters of glycemic variability calculated from cgm data, such as sd and mage, were increased as atherosclerosis progressed in patients with type 2 diabetes, and that increases in carotid intima-media thickness correlated significantly with mage [18]. |
| PubMedID- 25953645 | Conclusions: the plasma level of mmp-7 and -12 are elevated in type 2 diabetes mellitus, associated with more severe atherosclerosis and an increased incidence of coronary events. |
| PubMedID- 22682537 | Furthermore, in multivariate logistic regression analysis, thigh circumference was an independent determinant factor for carotid atherosclerosis in patients with type 2 diabetes even after adjusting for other cardiovascular risk factors. |
| PubMedID- 23387219 | [the correlation of serum cystatin c level with the severity of carotid atherosclerosis in patients with type 2 diabetes mellitus]. |
| PubMedID- 23337395 | Aim: to evaluate the expression of atherosclerosis-associated genes in patients with hypertension and type 2 diabetes mellitus. |
| PubMedID- 24843462 | Aims/introduction: the present study was designed to determine the effects of pioglitazone on glycemic control and atherosclerosis in patients with poorly controlled type 2 diabetes on insulin therapy. |
| PubMedID- 25168108 | Objective: to explore the potential association between the serum levels of 25-hydroxyvitamin d [25(oh)d] and carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 20923475 | However, the association between prehypertension and atherosclerosis in type 2 diabetes mellitus (t2dm) has not been evaluated. |
| PubMedID- 25708055 | In conclusion, cumulative active and passive smoking exposures are significant risk factors for carotid atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 25602196 | While in human atherosclerosis study, in patients with type 2 diabetes, an average annual increase of imt 0.02 mm/year has been reported [17,18]. |
| PubMedID- 26251624 | The development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm) may be due to hypercoagulability and platelet hyperaggregability,1,2 along with increased levels of platelet activation markers. |
| PubMedID- 23799122 | In conclusion, our study suggests that serum lipocalin-2 or rbp4 levels reflect subclinical atherosclerosis in adults with newly diagnosed type 2 diabetes. |
| PubMedID- 20361178 | This pathogenic sequence establishes the molecular basis linking insulin resistance, inflammation and accelerated atherosclerosis in people with type 2 diabetes mellitus and may help account for the missing 30% cvd risk that cannot be explained by circulating cardiovascular risk factors [74, 76] (fig. |
| PubMedID- 25253014 | Conclusion: the systolic longitudinal myocardial function of lv become compromised before reduced lv global systolic function in coronary atherosclerosis patients with type 2 diabetes mellitus. |
| PubMedID- 21192815 | Right coronary wall cmr in asymptomatic older subjects showed increased coronary atherosclerosis in subjects with type 2 diabetes as well as coronary calcification. |
| PubMedID- 26184626 | Favorable impact on ldl particle size in response to treatment with pioglitazone is associated with less progression of coronary atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 21668821 | The aim of this study was to determine whether antibodies against apolipoprotein b100 modified by methylglyoxal (mgo-apob100) are associated with coronary atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 22333479 | High serum levels of s100a8/a9 are associated with acute coronary syndrome and atherosclerosis in type 2 diabetes mellitus (t2dm). |
| PubMedID- 24772442 | Conclusions: ccta may be used as a non-invasive modality for evaluating and predicting vulnerable coronary atherosclerosis plaques in patients with type 2 diabetes. |
| PubMedID- 25619262 | [30] explored aspects of nadph oxidase c242t polymorphism in pathogenesis of carotid atherosclerosis in patients with type 2 diabetes, and found no significant association of c242t polymorphism in the nadph gene with clinical parameters, including plaque score and intima-media thickness of the carotid artery, using the 75th percentile of intima-media thickness as a cut-off value. |
| PubMedID- 21996253 | Aims: to analyze the relationship between serum levels of osteocalcin and parameters of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25589482 | Given the multi-faceted pathogenesis of atherosclerosis in type 2 diabetes mellitus (t2dm), it is likely that interventions to mitigate this risk must address cardiovascular (cv) risk factors beyond glucose itself. |
| PubMedID- 25806115 | It is critical to identify high-risk individuals for atherosclerosis among patients with type 2 diabetes because the burden for progression of arterial stiffness as shown by increased pwv is strongly associated with cardiovascular outcomes3031 as well as diabetic kidney disease.32 this study sheds light on the importance of evaluating visceral adiposity even in individuals with normal bmi among patients with type 2 diabetes. |
| PubMedID- 22267416 | Intima-media thickness and other markers of atherosclerosis in patients with type 2 diabetes and periodontal disease. |
| PubMedID- 26505665 | Method: this case-control study included 596 type 2 diabetes mellitus patients with carotid atherosclerosis and 379 patients without carotid atherosclerosis. |
| PubMedID- 24607023 | Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using dpp-4 inhibitor: the sitagliptin preventive study of intima-media thickness evaluation (spike). |
| PubMedID- 26388951 | Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in type 2 diabetes (boat2 study). |
| PubMedID- 26069232 | Little data exist about the relationship of apoc-iii, triglycerides, and atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23375680 | Conclusion: reduction of glucose excursion due to dpp-iv inhibitors administration, may prevent atherosclerosis progression in patients with type 2 diabetes probably through the reduction of daily inflammation and oxidative stress. |
| PubMedID- 24843653 | Epidemiological studies suggest that uric acid concentration correlates with urinary albumin excretion and subclinical atherosclerosis in patients with type 2 diabetes21, and lowering uric acid could slow the progression of renal disease in non‐diabetic patients22. |
| PubMedID- 23574730 | Postprandial hyperglycemia and/or hyperlipidemia can contribute to development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25851542 | [33] suggested that ga was a more valuable index than hba1c for predicting the progression of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 22483261 | type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events. |
| PubMedID- 23230750 | Conclusion: glucose excursions may contribute to the development of atherosclerosis in patients with type 2 diabetes, which is independent from hba1c levels. |
| PubMedID- 20194881 | Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. |
| PubMedID- 25623634 | Recent studies indicate that irisin is associated with endothelial dysfunction and atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 23904855 | In this study, the total number for atherosclerosis in patients with type 2 diabetes mellitus increased with the progression of renal dysfunction. |
| PubMedID- 20807873 | atherosclerosis is accelerated in patients with type 2 diabetes and underlies their higher incidence of cardiovascular disease (cvd) events. |
| PubMedID- 21748474 | Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 24295032 | Disturbances in the autonomic system modulation seem to precede the increase in the thickness of the carotid intima, a predictor of atherosclerosis progression in patients with type 2 diabetes [6,7]. |
| PubMedID- 20134102 | Genetic risk factors and the anti-atherosclerotic effect of pioglitazone on carotid atherosclerosis of subjects with type 2 diabetes--a retrospective study. |
| PubMedID- 21227528 | Association of serum trail levels with atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 26069717 | Although there is a clear association between endothelial dysfunction and atherosclerosis in type 2 diabetes, a cause-effect relationship is less clear in t1dm. |
| PubMedID- 24200881 | Conclusion: levels of urinary albumin excretion, but not reduced egfr, were associated with increased arterial stiffness, left ventricular mass and atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 24884694 | Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 21483695 | Part of the increased susceptibility to atherosclerosis of patients with type 2 diabetes mellitus and the metabolic syndrome has been attributed to the decreased clearance of trps [5], [31], [32]. |